A new study identifies key features that can improve diagnosis and guide therapy decisions for patients whose esophageal cancer presents at the T2N0 stage, when it is most treatable.
Patients with early esophageal cancer and risk of lymph node metastasis are best treated with surgical resection. For those over 65 or with significant comorbidities, endoscopic resection with adjuvant chemoradiation can be considered.
A prototype blood-based screening test evaluated by Cleveland Clinic researchers and others can accurately detect and localize multiple types of cancer, often before symptoms show. The promising results raise hopes that the assay will help achieve the long-sought goal of population-scale early detection of cancer.
Learn how Cleveland Clinic is advancing gastrointestinal care: Examining the link between IBD and liver disease, predicting progression in Barrett’s esophagus and investigating stem cell therapy for Crohn’s disease.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic has used endoscopic submucosal dissection since 2013 to treat patients with early-stage gastric and esophageal tumors. Dr. Bhatt, who introduced the technique to the health system, discusses its evolution, clinical application, and the results of new outcomes research.